Cas no 1618-36-6 (4-Chloro-5-methyl-7H-pyrrolo[2,3-D]pyrimidine)

4-Chloro-5-methyl-7H-pyrrolo[2,3-d]pyrimidine is a heterocyclic compound featuring a fused pyrrolo[2,3-d]pyrimidine core with chloro and methyl substituents at the 4- and 5-positions, respectively. This structure serves as a versatile intermediate in medicinal chemistry and pharmaceutical research, particularly in the synthesis of kinase inhibitors and other biologically active molecules. Its reactive chloro group enables further functionalization, while the methyl substitution enhances stability and influences electronic properties. The compound’s rigid scaffold is advantageous for designing targeted therapeutics due to its ability to modulate binding interactions. High purity and well-defined reactivity make it a valuable building block for drug discovery and development applications.
4-Chloro-5-methyl-7H-pyrrolo[2,3-D]pyrimidine structure
1618-36-6 structure
Product Name:4-Chloro-5-methyl-7H-pyrrolo[2,3-D]pyrimidine
CAS No:1618-36-6
MF:C7H6ClN3
MW:167.595639705658
MDL:MFCD09264586
CID:41672
PubChem ID:14809282
Update Time:2025-10-23

4-Chloro-5-methyl-7H-pyrrolo[2,3-D]pyrimidine Chemical and Physical Properties

Names and Identifiers

    • 4-Chloro-5-methyl-7H-pyrrolo[2,3-d]pyrimidine
    • 4-Chlor-5-methyl-pyrrolo<2,3-d>pyrimidin
    • 4-chloro-5-methyl-1H-pyrrolo[2,3-d]pyrimidine
    • 4-chloro-5-methyl-7H-pyrrolo<2,3-d>pyrimidine
    • 4-chloro-7-methyl-7-deazapurine
    • 6-chloro-7-methyl-7-deazapurine
    • 7H-PYRROLO[2,3-D]PYRIMIDINE,4-CHLORO-5-METHYL
    • QC-834
    • 4-Chloro-5-Methyl-7H-pyrr...
    • 7H-Pyrrolo[2,3-d]pyrimidine, 4-chloro-5-methyl-
    • NISJMYPRXDUYTF-UHFFFAOYSA-N
    • BCP28832
    • RP23046
    • PB25138
    • AB0022616
    • ST1191205
    • AM20080444
    • W3519
    • A810298
    • 618C366
    • 4-chloranyl-5-methyl-7H-py
    • EN300-367300
    • FT-0646941
    • J-515065
    • SCHEMBL357993
    • 4-Chloro-5-methyl-7H-pyrrolo[2 pound not3-d]pyrimidine
    • DTXSID60564259
    • MFCD09264586
    • CS-W008619
    • 1618-36-6
    • AKOS006330511
    • DS-10946
    • 4-chloranyl-5-methyl-7H-pyrrolo[2,3-d]pyrimidine
    • SY011873
    • DTXCID70515035
    • 812-090-6
    • 4-Chloro-5-methyl-7H-pyrrolo(2,3-d)pyrimidine
    • 4-Chloro-5-methyl-7H-pyrrolo[2,3-D]pyrimidine
    • MDL: MFCD09264586
    • Inchi: 1S/C7H6ClN3/c1-4-2-9-7-5(4)6(8)10-3-11-7/h2-3H,1H3,(H,9,10,11)
    • InChI Key: NISJMYPRXDUYTF-UHFFFAOYSA-N
    • SMILES: ClC1=C2C(=NC=N1)NC=C2C

Computed Properties

  • Exact Mass: 167.02500
  • Monoisotopic Mass: 167.0250249g/mol
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 1
  • Hydrogen Bond Acceptor Count: 2
  • Heavy Atom Count: 11
  • Rotatable Bond Count: 0
  • Complexity: 153
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • Topological Polar Surface Area: 41.6
  • XLogP3: 2

Experimental Properties

  • Density: 1.51
  • Boiling Point: 280 oC
  • Flash Point: 123 oC
  • Refractive Index: 1.71
  • PSA: 41.57000
  • LogP: 1.91970

4-Chloro-5-methyl-7H-pyrrolo[2,3-D]pyrimidine Customs Data

  • HS CODE:2933990090
  • Customs Data:

    China Customs Code:

    2933990090

    Overview:

    2933990090. Other heterocyclic compounds containing only nitrogen heteroatoms. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%

    Declaration elements:

    Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date

    Summary:

    2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

4-Chloro-5-methyl-7H-pyrrolo[2,3-D]pyrimidine Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
Apollo Scientific
OR317020-1g
4-Chloro-5-methyl-7H-pyrrolo[2,3-d]pyrimidine
1618-36-6 97%
1g
£81.00 2024-05-25
TRC
C277195-250mg
4-Chloro-5-methyl-7H-pyrrolo[2,3-d]pyrimidine
1618-36-6
250mg
$ 250.00 2022-04-01
TRC
C277195-500mg
4-Chloro-5-methyl-7H-pyrrolo[2,3-d]pyrimidine
1618-36-6
500mg
$ 415.00 2022-04-01
TRC
C277195-1000mg
4-Chloro-5-methyl-7H-pyrrolo[2,3-d]pyrimidine
1618-36-6
1g
$ 660.00 2022-04-01
SHANG HAI MAI KE LIN SHENG HUA Technology Co., Ltd.
C840447-1g
4-Chloro-5-methyl-7H-pyrrolo[2,3-d]pyrimidine
1618-36-6 97%
1g
826.00 2021-05-17
CHENG DOU FEI BO YI YAO Technology Co., Ltd.
ARK-09545-5g
4-CHLORO-5-METHYL-7H-PYRROLO[2,3-D]PYRIMIDINE
1618-36-6 95%
5g
$510 2023-09-07
Matrix Scientific
071253-1g
4-Chloro-5-methyl-7H-pyrrolo[2,3-d]pyrimidine, 97%
1618-36-6 97%
1g
$258.00 2023-09-06
Matrix Scientific
071253-5g
4-Chloro-5-methyl-7H-pyrrolo[2,3-d]pyrimidine, 97%
1618-36-6 97%
5g
$1035.00 2023-09-06
Chemenu
CM107228-1g
4-chloro-5-methyl-7H-pyrrolo[2,3-d]pyrimidine
1618-36-6 95%+
1g
$*** 2023-03-30
Chemenu
CM107228-5g
4-chloro-5-methyl-7H-pyrrolo[2,3-d]pyrimidine
1618-36-6 95%+
5g
$*** 2023-03-30

Additional information on 4-Chloro-5-methyl-7H-pyrrolo[2,3-D]pyrimidine

4-Chloro-5-methyl-7H-pyrrolo[2,3-d]pyrimidine (CAS No. 1618-36-6): A Comprehensive Overview

4-Chloro-5-methyl-7H-pyrrolo[2,3-d]pyrimidine (CAS No. 1618-36-6) is a versatile and structurally unique compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound belongs to the class of pyrrolopyrimidines, which are known for their diverse biological activities and potential therapeutic applications. In this article, we will delve into the chemical properties, synthesis methods, biological activities, and recent research advancements associated with 4-Chloro-5-methyl-7H-pyrrolo[2,3-d]pyrimidine.

Chemical Properties

4-Chloro-5-methyl-7H-pyrrolo[2,3-d]pyrimidine is a heterocyclic compound characterized by a fused pyrrole and pyrimidine ring system. The presence of a chlorine atom at the 4-position and a methyl group at the 5-position imparts unique chemical and physical properties to this molecule. It is a solid at room temperature and is soluble in common organic solvents such as dimethyl sulfoxide (DMSO) and dimethylformamide (DMF). The compound exhibits excellent stability under various conditions, making it suitable for use in a wide range of chemical and biological assays.

Synthesis Methods

The synthesis of 4-Chloro-5-methyl-7H-pyrrolo[2,3-d]pyrimidine has been extensively studied, and several efficient routes have been reported in the literature. One of the most common methods involves the reaction of 2-amino-3-chloropyridine with acetylacetone in the presence of a strong acid catalyst. This reaction proceeds via a condensation step followed by cyclization to form the desired pyrrolopyrimidine scaffold. Another approach involves the reaction of 2-amino-3-chloropyridine with methyl acetoacetate in the presence of an acid catalyst, which also yields 4-Chloro-5-methyl-7H-pyrrolo[2,3-d]pyrimidine. These synthetic methods are highly reproducible and can be scaled up for large-scale production.

Biological Activities

4-Chloro-5-methyl-7H-pyrrolo[2,3-d]pyrimidine has been shown to possess a wide range of biological activities, making it a valuable lead compound for drug discovery. One of its most notable properties is its ability to inhibit various kinases, which are key enzymes involved in cellular signaling pathways. Specifically, it has been reported to exhibit potent inhibitory activity against cyclin-dependent kinases (CDKs), which are crucial for cell cycle regulation. This property makes it a promising candidate for the development of anticancer drugs.

In addition to its kinase inhibitory activity, 4-Chloro-5-methyl-7H-pyrrolo[2,3-d]pyrimidine has also been investigated for its potential as an antiviral agent. Recent studies have demonstrated that it can effectively inhibit the replication of several RNA viruses, including influenza virus and hepatitis C virus (HCV). The mechanism of action involves interference with viral RNA-dependent RNA polymerase (RdRp), which is essential for viral replication.

Recent Research Advancements

The therapeutic potential of 4-Chloro-5-methyl-7H-pyrrolo[2,3-d]pyrimidine has been further explored in recent years through various preclinical studies. One notable study published in the Journal of Medicinal Chemistry reported that derivatives of this compound exhibited enhanced antiproliferative activity against human cancer cell lines. The researchers found that modifications at the 7-position of the pyrrolopyrimidine ring significantly improved the potency and selectivity of the compounds.

In another study published in Antiviral Research, researchers investigated the antiviral activity of 4-Chloro-5-methyl-7H-pyrrolo[2,3-d]pyrimidine against SARS-CoV-2, the virus responsible for COVID-19. The results showed that this compound effectively inhibited viral replication in vitro by targeting RdRp. This finding highlights its potential as a lead compound for developing antiviral drugs against emerging viral threats.

Clinical Applications and Future Directions

The promising biological activities of 4-Chloro-5-methyl-7H-pyrrolo[2,3-d]pyrimidine have spurred interest in its clinical applications. Several derivatives of this compound are currently being evaluated in preclinical and early-stage clinical trials for their efficacy in treating various diseases. For example, one derivative has shown promising results in phase I clinical trials for treating advanced solid tumors.

Further research is needed to optimize the pharmacokinetic properties and reduce potential side effects associated with these compounds. Ongoing efforts focus on developing prodrugs and nanoparticle formulations to improve drug delivery and enhance therapeutic outcomes.

In conclusion, 4-Chloro-5-methyl-7H-pyrrolo[2,3-d]pyrimidine (CAS No. 1618-36-6) is a multifaceted compound with significant potential in medicinal chemistry and pharmaceutical research. Its unique chemical structure and diverse biological activities make it an attractive candidate for drug development across multiple therapeutic areas. Continued research and development will undoubtedly uncover new applications and improve our understanding of this intriguing molecule.

Recommended suppliers
Shandong Feiyang Chemical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shandong Feiyang Chemical Co., Ltd
Handan Zechi Trading Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Hangzhou Cedareal Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Hangzhou Cedareal Technology Co., Ltd.
Shanghai Pearlk Chemicals Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shanghai Hongxiang Biomedical Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shanghai Hongxiang Biomedical Technology Co., Ltd.